Business Description
Ibex Technologies Inc
NAICS : 325412
SIC : 3741
ISIN : CA4489375085
Compare
Compare
Traded in other countries / regions
IBT.CanadaIBT.GermanyIBXNF.USA IPO Date
1986-12-22Description
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.52 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 0.54 | |||||
Interest Coverage | 15.66 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.41 | |||||
Beneish M-Score | -1.37 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.2 | |||||
3-Year EBITDA Growth Rate | 11.3 | |||||
3-Year EPS without NRI Growth Rate | 80.1 | |||||
3-Year FCF Growth Rate | -2 | |||||
3-Year Book Growth Rate | 24.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 88.47 | |||||
9-Day RSI | 75.98 | |||||
14-Day RSI | 72.72 | |||||
6-1 Month Momentum % | 46.39 | |||||
12-1 Month Momentum % | 71.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.23 | |||||
Quick Ratio | 6.08 | |||||
Cash Ratio | 5.16 | |||||
Days Inventory | 36.55 | |||||
Days Sales Outstanding | 53.87 | |||||
Days Payable | 235.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.42 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.11 | |||||
Operating Margin % | 24.08 | |||||
Net Margin % | 49.7 | |||||
FCF Margin % | 22.23 | |||||
ROE % | 31.02 | |||||
ROA % | 25.1 | |||||
ROIC % | 55.76 | |||||
ROC (Joel Greenblatt) % | 68.03 | |||||
ROCE % | 17.09 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 9.47 | |||||
PE Ratio without NRI | 9.47 | |||||
Shiller PE Ratio | 29.17 | |||||
Price-to-Owner-Earnings | 9 | |||||
PS Ratio | 4.78 | |||||
PB Ratio | 2.48 | |||||
Price-to-Tangible-Book | 2.48 | |||||
Price-to-Free-Cash-Flow | 20.87 | |||||
Price-to-Operating-Cash-Flow | 14.55 | |||||
EV-to-EBIT | 11.63 | |||||
EV-to-EBITDA | 9.63 | |||||
EV-to-Revenue | 3.52 | |||||
EV-to-FCF | 15.84 | |||||
Price-to-Projected-FCF | 1.43 | |||||
Price-to-Median-PS-Value | 4.5 | |||||
Price-to-Graham-Number | 1.02 | |||||
Price-to-Net-Current-Asset-Value | 4.65 | |||||
Price-to-Net-Cash | 6.26 | |||||
Earnings Yield (Greenblatt) % | 8.6 | |||||
FCF Yield % | 5.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ibex Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 7.998 | ||
EPS (TTM) (C$) | 0.152 | ||
Beta | 0 | ||
Volatility % | 37.71 | ||
14-Day RSI | 72.72 | ||
14-Day ATR (C$) | 0.006361 | ||
20-Day SMA (C$) | 1.4325 | ||
12-1 Month Momentum % | 71.08 | ||
52-Week Range (C$) | 0.77 - 1.45 | ||
Shares Outstanding (Mil) | 24.51 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ibex Technologies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ibex Technologies Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Ibex Technologies Inc Frequently Asked Questions
What is Ibex Technologies Inc(TSXV:IBT)'s stock price today?
The current price of TSXV:IBT is C$1.44. The 52 week high of TSXV:IBT is C$1.45 and 52 week low is C$0.77.
When is next earnings date of Ibex Technologies Inc(TSXV:IBT)?
The next earnings date of Ibex Technologies Inc(TSXV:IBT) is .
Does Ibex Technologies Inc(TSXV:IBT) pay dividends? If so, how much?
Ibex Technologies Inc(TSXV:IBT) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |